Stocks
Huang's Hidden Gem: Nvidia CEO Invests Heavily in AI-Driven Biotech
Nvidia CEO Jensen Huang has invested $10.4 million in Generate Biomedicines, a clinical-stage biotech company that went public this past February with an initial public offering (IPO).
The company's AI platform, called the Generate Platform, is designed to accelerate and improve the success rate of creating new therapeutics.
Generate uses proprietary machine-learning architectures to engineer novel, tailor-made protein therapeutics from scratch, targeting disease pathways that legacy drug discovery methods struggle to reach.